Scientists test inhaled TB vaccine to boost protection for High-Risk diabetics
NCT ID NCT06246851
Summary
This study aims to see if giving a TB vaccine booster through an inhaled mist is more effective than the standard skin injection. Researchers will compare immune responses in 36 adults who received the BCG vaccine as children, including a group with type 2 diabetes. The goal is to gather knowledge to improve future vaccine strategies for people at higher risk of tuberculosis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Clinical Vaccinology and Tropical Medicine
Oxford, Oxfordshire, OX3 7LE, United Kingdom
Conditions
Explore the condition pages connected to this study.